Legal & General Group’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-29,738
| Closed | -$1.38M | – | 3441 |
|
|
2023
Q2 | $1.38M | Buy |
29,738
+13,963
| +89% | +$649K | ﹤0.01% | 2084 |
|
|
2023
Q1 | $452K | Buy |
15,775
+1,437
| +10% | +$41.2K | ﹤0.01% | 2342 |
|
|
2022
Q4 | $447K | Buy |
14,338
+9,256
| +182% | +$289K | ﹤0.01% | 2367 |
|
|
2022
Q3 | $104K | Buy |
5,082
+318
| +7% | +$6.51K | ﹤0.01% | 2813 |
|
|
2022
Q2 | $74K | Buy |
4,764
+3,459
| +265% | +$53.7K | ﹤0.01% | 2924 |
|
|
2022
Q1 | $25K | Buy |
1,305
+15
| +1% | +$287 | ﹤0.01% | 3179 |
|
|
2021
Q4 | $33K | Buy |
+1,290
| New | +$33K | ﹤0.01% | 3126 |
|